Amylyx Pharmaceuticals, Inc. (AMLX)
27.79
-2.50
(-8.25%)
USD |
NASDAQ |
Nov 16, 16:00
27.79
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals Total Assets (Quarterly) : 786.80M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 786.80M |
| June 30, 2026 | 264.56M |
| March 31, 2026 | 293.60M |
| December 31, 2025 | 334.07M |
| September 30, 2025 | 362.74M |
| June 30, 2025 | 194.60M |
| March 31, 2025 | 219.68M |
| December 31, 2024 | 193.63M |
| September 30, 2024 | 250.71M |
| June 30, 2024 | 332.16M |
| March 31, 2024 | 417.46M |
| December 31, 2023 | 517.45M |
| Date | Value |
|---|---|
| September 30, 2023 | 466.58M |
| June 30, 2023 | 453.59M |
| March 31, 2023 | 407.96M |
| December 31, 2022 | 391.45M |
| September 30, 2022 | 181.44M |
| June 30, 2022 | 225.24M |
| March 31, 2022 | 274.44M |
| December 31, 2021 | 105.61M |
| September 30, 2021 | 130.46M |
| June 30, 2021 | |
| March 31, 2021 | |
| December 31, 2020 | 14.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Pfizer Inc. | 204.54B |
| ANI Pharmaceuticals, Inc. | 1.568B |
| Corcept Therapeutics, Inc. | 1.034B |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 197.42B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 33.06M |
| Shareholders Equity (Quarterly) | 753.74M |
| Debt to Equity Ratio | 0.0066 |
| Current Ratio | 26.81 |
| Net Debt Paydown Yield | 0.01% |